Dendritic cell (DC) vaccines induce specific immune responses that can selectively
eliminate target cells. In recent years, many studies have been conducted to explore DC …

The development of immunotherapeutic methods for the treatment of oncological diseases
have made it possible to improve the effectiveness of standard therapies. There was no …

Sarcomas are uncommon malignancies of mesenchymal origin that can arise throughout the
human lifespan, at any part of the body. Surgery remains the optimal treatment modality …

The malignant form of melanoma is one of the deadliest human cancers that accounts for
almost all of the skin tumor-related fatalities in its later stages. Achieving an exhaustive …

Colorectal cancer (CRC) remains a leading cause of cancer-related deaths in the United
States despite an array of available treatment options. Current standard-of-care …

Cancer immunotherapy is fast becoming one of the most promising means of treating
malignant disease. Cancer vaccines, adoptive cell transfer therapies, and immune …

Dendritic cells (DCs) comprise diverse cell populations that play critical roles in antigen
presentation and triggering immune responses in the body. However, several factors impair …

Background Glioblastoma (GBM) is a poor prognosis grade 4 glioma. After surgical
resection, the standard therapy consists of concurrent radiotherapy (RT) and temozolomide …

Introduction Develo** a safe and efficacious vaccine that can induce broad and long-term
immunity for SARS-CoV-2 infection is the most critical research to date. As the most potent …

Simple Summary The clinical success of immunotherapies using immune checkpoint
blockers deployed in melanoma strongly supports that the immune system can efficiently …